Medpace Holdings Inc. (MEDP)
Medpace (MEDP) Stock Slides as Market Rises: Facts to Know Before You Trade
Medpace (MEDP) closed at $445.59 in the latest trading session, marking a -1.3% move from the prior day.
LH or MEDP: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Medpace: Off The Pace Here Amidst Continued Booking Softness
Medpace's shares have sharply declined following a disappointing quarterly earnings report. A soft start to the year raises concerns about Medpace's near-term growth trajectory and operational momentum. The earnings miss may prompt investors to reassess MEDP's valuation and forward expectations.
Medpace Holdings: Downgrade To 'Buy' As Revenue Growth Remains, But With Caution Ahead
Medpace Holdings is downgraded from 'Strong Buy' to 'Buy' due to rising backlog cancellations and elevated direct costs, despite robust revenue growth. MEDP delivered Q1 2026 revenue of $706.6M (+26.5% YoY) and beat both top- and bottom-line expectations, with strong Net New Business Awards growth. The Net Book-to-Bill ratio fell to 0.88x in Q1 2026, driven by the highest backlog cancellations in over a year, warranting caution.
Down 15.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Medpace (MEDP)
The heavy selling pressure might have exhausted for Medpace (MEDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Medpace Holdings, Inc. (MEDP) Q1 2026 Earnings Call Transcript
Medpace Holdings, Inc. (MEDP) Q1 2026 Earnings Call Transcript
Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates
Medpace (MEDP) came out with quarterly earnings of $4.28 per share, beating the Zacks Consensus Estimate of $3.74 per share. This compares to earnings of $3.67 per share a year ago.
Medpace Crashes: Here's What Overshadowed Its First-Quarter Sales, Earnings Beat
Medpace stock crashed late Wednesday after a booking miss overshadowed an otherwise strong first-quarter report and guidance hike.
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.
Why Medpace (MEDP) Outpaced the Stock Market Today
In the closing of the recent trading day, Medpace (MEDP) stood at $501.23, denoting a +1.56% move from the preceding trading day.
Medpace (MEDP) Laps the Stock Market: Here's Why
In the closing of the recent trading day, Medpace (MEDP) stood at $508.52, denoting a +2.52% move from the preceding trading day.
Medpace (MEDP) Beats Stock Market Upswing: What Investors Need to Know
In the most recent trading session, Medpace (MEDP) closed at $489.48, indicating a +1.93% shift from the previous trading day.
